Info: Read More
  • 中药标准品生产商,产品定制服务
  • 海罂粟碱

    Glaucine

    海罂粟碱
    产品编号 CFN90408
    CAS编号 475-81-0
    分子式 = 分子量 C21H25NO4 = 355.43
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Alkaloids
    植物来源 The tubers of Corydalis yanhusuo
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    海罂粟碱 CFN90408 475-81-0 10mg QQ客服:2056216494
    海罂粟碱 CFN90408 475-81-0 20mg QQ客服:2056216494
    海罂粟碱 CFN90408 475-81-0 50mg QQ客服:2056216494
    海罂粟碱 CFN90408 475-81-0 100mg QQ客服:2056216494
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • Korea Intitute of Science and Technology (KIST) (Korea)
  • Centralised Purchases Unit (CPU), B.I.T.S (India)
  • Tokyo Woman's Christian University (Japan)
  • The Institute of Cancer Research (United Kingdom)
  • University of Parma (Italy)
  • Istanbul University (Turkey)
  • Heidelberg University (Germany)
  • University of Limpopo (South Africa)
  • University of Lodz (Poland)
  • Washington State University (USA)
  • Uniwersytet Gdański (Poland)
  • Max-Planck-Insitut (Germany)
  • Heinrich-Heine-University Düsseldorf (Germany)
  • University of Perugia (Italy)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Journal of Third Military Medical University2019, 41(2):110-115
  • Int J Mol Med.2016, 37(2):501-8
  • Environ Toxicol.2023, 23929.
  • Molecules.2023, 28(8):3414.
  • Acta Biochim Pol.2015, 62(2):253-8
  • Sci Adv.2018, 4(10)
  • J Food Sci.2022, 87(11):4905-4916.
  • The Journal of Internal Korean Medicine2015, 36(4):486-497
  • J Agric Food Chem.2020, 68(51):15164-15175
  • JEJU National University2022, 10478.
  • Sci Rep. 2017, 12953(7)
  • Ulm University Medical Center2020, doi: 10.18725.
  • Horticulture Research2023, uhad259
  • J Chromatogr A.2022, 1685:463640.
  • Pharmacol Rep.2022, 74(1):175-188.
  • J Food Sci.2021, 86(9):3810-3823.
  • Int Immunopharmacol.2023, 7:127:111322.
  • Crystals2020, 10(3), 206.
  • Applied Biological Chemistry2023, 66(58):112.
  • Korean Journal of Pharmacognosy2017, 48(4):320-328
  • Clin Exp Pharmacol Physiol.2015, 42(11):1189-97
  • J Ethnopharmacol.2016, 194:219-227
  • Process Biochemistry2019, 85:106-115
  • ...
  • 生物活性
    Description: Glaucine has antitussive, antioxidative potential and antiviral activities, it may be an anti-arthritic agent, it can enhance LPS and zymosan-induced IL-10 production. Glaucine can inhibit the migration and invasion of human breast cancer cells by MMP-9 inhibitory activity, attenuating IκBα and NF-κB activities.
    Targets: MMP(e.g.TIMP) | NF-kB | JAK | STAT | TLR | IL Receptor | TNF-α
    In vitro:
    Biochem Pharmacol. 2013 Nov 15;86(10):1497-506.
    Studies on the in vivo contribution of human cytochrome P450s to the hepatic metabolism of glaucine, a new drug of abuse.[Pubmed: 23988488]
    Glaucine ((S)-5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo [de,g]quinoline), main isoquinoline alkaloid of Glaucium flavum (Papaveraceae), is used as antitussive, but also as recreational drug of abuse. Glaucine was mainly metabolized by O- and N-demethylation to four isomers in rats. So far, only scarce pharmacokinetic data were available. Therefore, the aim of the presented study was to assess the involvement of the ten most important cytochrome P450 (P450) isoforms in the main metabolic steps and determination of their kinetic parameters using the metabolite formation approach.
    METHODS AND RESULTS:
    Reference standards of investigated metabolites were synthesized for quantification. In addition, the impact of isomeric standards was tested for calibration and the use of simple peak area ratios on the kinetic constants and resulting contribution of P450 isoforms on estimated hepatic clearance. Kinetic profiles of all metabolite formations followed classic Michaelis-Menten behavior. Km values were between 25 and 140μM, Vmax between 0.10 and 1.92pmol/min/pmol. Using the relative activity factor approach, the hepatic clearance was calculated to be 27 and 73% for 2-O-demethylation by CYP1A2 and CYP3A4, 82, 3, and 15% for 9-O-demethylation by CYP1A2, CYP2C19, and CYP2D6, and finally <1 and 99% for N-demethylation by CYP2D6 and CYP3A4.
    CONCLUSIONS:
    These data were confirmed by inhibition tests. The calibration mode for determination of the metabolite concentrations had no relevant impact on the estimation of in vivo hepatic clearance of glaucine. As glaucine was metabolized via three initial steps and different P450 isoforms were involved in the hepatic clearance of glaucine, a clinically relevant interaction with single inhibitors should not be expected.
    Bioorg Med Chem. 2008 Aug 1;16(15):7457-61.
    Cinnamoyl- and hydroxycinnamoyl amides of glaucine and their antioxidative and antiviral activities.[Pubmed: 18590964 ]
    The aporphine alkaloid glaucine has been converted into 3-aminomethylglaucine and its free amino group has been linked to cinnamic, ferulic, sinapic, o-, and p-coumaric acids.
    METHODS AND RESULTS:
    The antioxidative potential of the synthesized amides was studied against DPPH(*) test. All of the tested compounds demonstrated higher radical scavenging activity than glaucine and 3-aminomethylglaucine, and lower antioxidative effect than the free hydroxycinnamic acids. The newly synthesized compounds were tested in vitro for antiviral activity against viruses belonging to different taxonomic groups.
    In vivo:
    Immunopharmacol Immunotoxicol. 2015 Feb;37(1):56-62.
    Acetylated derivative of glaucine inhibits joint inflammation in collagenase-induced arthritis.[Pubmed: 25328086]
    Osteoarthritis (OA) has become by far the most common joint disorder. A number of studies using OA animal models have explored the effects of agents that can modulate bone metabolism. In the present study, we investigated the effect of acetylated derivative of plant alkaloid glaucine (ADG) on experimental OA in mice.
    METHODS AND RESULTS:
    Arthritis was induced by two intraarticular (i.a.) injections of collaganase. Histopathological changes were observed through hematoxylin and eosine (H&E), safranin O and toluidine blue staining. Differentiation of bone marrow (BM) cells was evaluated by tartarate-resistant acid phosphatase (TRAP) assay. The expression of phospho-Janus kinase 2 (pJAK2) and phospho signal transducer and activator of transcription3 (pSTAT3) expression in the joints was determined by immunohistochemistry. We established that ADG significantly decreased cell infiltration (2.32 ± 0.14 versus 1.62 ± 0.13), cartilage loss (2.42 ± 0.12 versus 1.12 ± 0.10) and bone erosion (1.76 ± 0.13 versus 1.04 ± 0.14) in arthritic mice. It appeared that the substance inhibited in a dose-dependent manner osteoclast differentiation in vitro. ADG suppressed the expression of pJAK2 in the joint and partially affected the expression of pSTAT3.
    CONCLUSIONS:
    Present results suggest that ADG is a suitable candidate for further development as an anti-arthritic agent.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 2.8135 mL 14.0675 mL 28.1349 mL 56.2699 mL 70.3373 mL
    5 mM 0.5627 mL 2.8135 mL 5.627 mL 11.254 mL 14.0675 mL
    10 mM 0.2813 mL 1.4067 mL 2.8135 mL 5.627 mL 7.0337 mL
    50 mM 0.0563 mL 0.2813 mL 0.5627 mL 1.1254 mL 1.4067 mL
    100 mM 0.0281 mL 0.1407 mL 0.2813 mL 0.5627 mL 0.7034 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    N-甲基钓樟卡品; N-Methyllindcarpine CFN99454 14028-97-8 C19H21NO4 = 327.4 5mg QQ客服:2159513211
    异紫堇定碱; (+)-Isocorynoline CFN90215 475-67-2 C20H23NO4 = 341.40 20mg QQ客服:2159513211
    紫菫定酚; Corydine CFN90527 476-69-7 C20H23NO4 = 341.40 5mg QQ客服:215959384
    紫堇块茎碱; Corytuberine CFN90528 517-56-6 C19H21NO4 = 327.37 5mg QQ客服:1413575084
    N-甲基-O10-甲基莲叶桐文; Litseglutine B CFN98279 25368-01-8 C20H23NO4 = 341.4 5mg QQ客服:2056216494
    波尔定碱; Boldine CFN98718 476-70-0 C19H21NO4 = 327.4 20mg QQ客服:2056216494
    无根藤辛; Cassythicine CFN98998 5890-28-8 C19H19NO4 = 325.4 5mg QQ客服:1457312923
    海罂粟碱; Glaucine CFN90408 475-81-0 C21H25NO4 = 355.43 20mg QQ客服:3257982914
    波尔定碱 2-甲醚; Lauroscholtzine CFN98078 2169-44-0 C20H23NO4 = 341.4 5mg QQ客服:3257982914
    Nantenine; Nantenine CFN89514 2565-01-7 C20H21NO4 = 339.38 5mg QQ客服:2159513211

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产